LifeStance Health Group (LFST) Competitors $4.24 +0.05 (+1.07%) As of 12:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFST vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, CON, PRVA, WGS, and VCYTShould you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. LifeStance Health Group vs. Its Competitors Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Concentra Group Holdings Parent Privia Health Group GeneDx Veracyte Guardant Health (NASDAQ:GH) and LifeStance Health Group (NASDAQ:LFST) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment. Do analysts prefer GH or LFST? Guardant Health currently has a consensus price target of $54.45, indicating a potential upside of 20.36%. LifeStance Health Group has a consensus price target of $8.50, indicating a potential upside of 100.24%. Given LifeStance Health Group's higher possible upside, analysts clearly believe LifeStance Health Group is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 20 Buy rating(s) 1 Strong Buy rating(s) 3.05LifeStance Health Group 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.83 Do institutionals & insiders believe in GH or LFST? 92.6% of Guardant Health shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 6.1% of Guardant Health shares are held by company insiders. Comparatively, 6.6% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, GH or LFST? Guardant Health has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Does the media favor GH or LFST? In the previous week, Guardant Health had 4 more articles in the media than LifeStance Health Group. MarketBeat recorded 10 mentions for Guardant Health and 6 mentions for LifeStance Health Group. Guardant Health's average media sentiment score of 0.79 beat LifeStance Health Group's score of 0.45 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive LifeStance Health Group 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation & earnings, GH or LFST? LifeStance Health Group has higher revenue and earnings than Guardant Health. LifeStance Health Group is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M7.58-$436.37M-$3.39-13.35LifeStance Health Group$1.25B1.32-$57.44M-$0.10-42.45 Is GH or LFST more profitable? LifeStance Health Group has a net margin of -2.78% compared to Guardant Health's net margin of -53.82%. Guardant Health's return on equity of 0.00% beat LifeStance Health Group's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-53.82% N/A -26.77% LifeStance Health Group -2.78%-2.47%-1.69% SummaryGuardant Health beats LifeStance Health Group on 9 of the 16 factors compared between the two stocks. Get LifeStance Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFST vs. The Competition Export to ExcelMetricLifeStance Health GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.65B$3.83B$5.64B$9.44BDividend YieldN/A1.36%4.01%4.02%P/E Ratio-42.3535.2328.3820.08Price / Sales1.32130.10413.5988.94Price / Cash105.1621.9635.9658.29Price / Book1.124.518.525.79Net Income-$57.44M$189.47M$3.24B$258.18M7 Day Performance-3.52%3.90%4.60%3.72%1 Month Performance-14.42%-1.87%12.61%14.51%1 Year Performance-23.79%-2.09%35.83%19.13% LifeStance Health Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFSTLifeStance Health Group3.0998 of 5 stars$4.25+1.1%$8.50+100.2%-24.7%$1.65B$1.25B-42.3510,218News CoverageGHGuardant Health4.5683 of 5 stars$49.77-1.0%$53.76+8.0%+44.5%$6.17B$739.02M-14.682,021Upcoming EarningsAnalyst RevisionOPCHOption Care Health4.5338 of 5 stars$30.68+2.7%$35.50+15.7%-4.4%$5.02B$5.00B24.748,088Positive NewsUpcoming EarningsRDNTRadNet3.7698 of 5 stars$56.59+2.0%$69.60+23.0%-8.8%$4.25B$1.87B-131.6011,021Positive NewsBTSGBrightSpring Health Services1.9733 of 5 stars$20.31flat$24.90+22.6%+68.5%$3.57B$11.86B72.5435,000SHCSotera Health3.2649 of 5 stars$11.61-1.6%$16.00+37.8%-13.5%$3.30B$1.10B145.143,000Positive NewsSGRYSurgery Partners2.8649 of 5 stars$22.47+2.0%$33.56+49.3%-21.7%$2.88B$3.11B-14.6915,000CONConcentra Group Holdings Parent3.0172 of 5 stars$20.23+1.6%$28.50+40.9%N/A$2.59B$1.90B15.0911,250PRVAPrivia Health Group4.1113 of 5 stars$20.89+2.1%$28.38+35.9%+2.3%$2.55B$1.80B174.101,140Positive NewsWGSGeneDx3.9532 of 5 stars$82.39-0.2%$92.33+12.1%+148.8%$2.35B$330.14M-58.431,200Upcoming EarningsVCYTVeracyte3.6723 of 5 stars$26.65-1.6%$40.90+53.5%+0.2%$2.09B$445.76M65.00790 Related Companies and Tools Related Companies GH Competitors OPCH Competitors RDNT Competitors BTSG Competitors SHC Competitors SGRY Competitors CON Competitors PRVA Competitors WGS Competitors VCYT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFST) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeStance Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
